MLA
JNJ icon

MB, Levis & Associates’s Johnson & Johnson JNJ Stock Holding History

MB, Levis & Associates’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.72M Buy
10,703
+14
+0.1% +$3.26K 1% 21
2026
Q1 		$2.61M Sell
10,689
-10
-0.1% -$2.33K 1.09% 18
2025
Q4 		$2.21M Sell
10,699
-129
-1% -$25.5K 0.93% 20
2025
Q3 		$2.01M Sell
10,828
-848
-7% -$145K 0.87% 23
2025
Q2 		$1.78M Buy
11,676
+135
+1% +$20.8K 0.78% 24
2025
Q1 		$1.91M Buy
11,541
+9
+0.1% +$1.41K 0.89% 20
2024
Q4 		$1.67M Buy
11,532
+36
+0.3% +$5.58K 0.84% 22
2024
Q3 		$1.86M Buy
11,496
+8
+0.1% +$1.27K 0.92% 21
2024
Q2 		$1.68M Buy
11,488
+101
+0.9% +$15K 0.88% 21
2024
Q1 		$1.8M Sell
11,387
-92
-0.8% -$14.6K 0.97% 21
2023
Q4 		$1.8M Buy
11,479
+45
+0.4% +$6.9K 1.03% 19
2023
Q3 		$1.78M Buy
11,434
+9
+0.1% +$1.49K 1.15% 17
2023
Q2 		$1.89M Sell
11,425
-28
-0.2% -$4.52K 1.21% 17
2023
Q1 		$1.78M Buy
11,453
+235
+2% +$37.9K 1.24% 17
2022
Q4 		$1.98M Buy
+11,218
New +$1.94M 1.55% 13

Other funds holding JNJ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

MB, Levis & Associates's JNJ Position: Q2 2026 in Review

MB, Levis & Associates increased its Johnson & Johnson (JNJ) stake by 0.13% in Q2 2026, buying an estimated $3.26K and bringing the position to 10,703 shares worth $2.72M. The position accounts for 1% of the portfolio, ranked #21.

MB, Levis & Associates first reported a position in JNJ in Q4 2022 and has held it in 15 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • MB, Levis & Associates held 10,703 shares of Johnson & Johnson worth $2.72M as of Q2 2026.
  • MB, Levis & Associates bought 14 Johnson & Johnson shares in Q2 2026, an estimated $3.26K.
  • Johnson & Johnson made up 1% of MB, Levis & Associates's portfolio in Q2 2026, its #21 holding.
  • MB, Levis & Associates first reported a position in Johnson & Johnson in Q4 2022 and has held it in 15 quarters since.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on MB, Levis & Associates's 13F filing for Q2 2026, filed 22 Jul 2026.